F rancis Bacon said "Science is measurement". In the recent development of presbyopic intraocular lenses (IOLs), a topic with an exciting historical development and today's ever-increasing passionate reality, measurement has become one of the key factors for their commercial evolution and clinical success.
The problem we have today on the market is not only about fake news, but also about masquerade news comments. We qualify this as commercially biased information which tries to obtain our favorable opinion about some lenses because they look different or they provide a different type of performance. Some of the so-called EDOF lenses available today are actually multifocal lenses with low power in which part of the rest of the power has been withdrawn to avoid the overlapping of images and the consequent halos and glare, by a certain standard of focus caused by the induction of spherical aberration to a certain level. The effect of EDOF on these lenses is mainly because of multifocality and not to the EDOF effect. Some concepts are wrongly used. For instance, achromatization does not bring an EDOF improvement but rather an improvement in the contrast sensitivity function. Multifocality, either refractive or diffractive, is not EDOF. The added value of the spherical aberration included will always influence near vision performance by <1 diopter but the EDOF effect will only work if the lens is properly matched to the spherical aberration of the cornea of the patient, which is still not feasible today.
In this special issue, the reader will find 2 interesting articles. In the first, Sudhir et al 4 offer an analysis of the literature on the performance of the AcrySof IQ PanOptix vs trifocal IOLs (FineVision Micro F a multifocal lens with EDOF effect and achromatization, the Tecnis Symfony ZXR00, which is a lowpower multifocal lens with some EDOF). 4 In their review, the authors find different performances reported by different authors, which is explained by the reading test techniques. 1 It is noteworthy that in the studies quoted by the authors, 5,6 up to 25% of the patients need near-vision glasses, 5 something that is expected as the decrease in IOL power is not always compensated by the EDOF, creating an insufficient amount of light for reading purposes.
In the other article, Nivean et al 7 report the outcomes of what they call a new generation of extended depth of focus IOL, which is actually a bifocal refractive lens with an EDOF profile. This lens, has a small central zone for near vision of þ3.5 D, is obviously not a real EDOF lens but rather a bifocal lens which offers a peripheral asphericity to increase the effectiveness for near vision as a support for the optical power of the lens.
EDOF lenses should be called as such only when they do not have either refractive or diffractive added multifocality. Multifocal EDOF lens is a better term for the presbyopic IOLs that are compared in these studies. They are basically multifocals with some components of EDOF which on practical terms have low predictability as the spherical aberration of the lens is not matched with that of the cornea of the eye in which it is going to be implanted. It is indeed fake news that only EDOF lenses can restore multifocality with good quality of far vision and near vision at the same time because they are not compatible.
The clarification of this issue is important for the modern refractive and cataract surgeon to understand which lens to use and what to expect from them. Putting great value on honesty and clarity, the industry should not masquerade multifocality with EDOF to increase the commercial value of the new multifocal lenses.
